Mi-thos® Transcatheter Mitral Valve Replacement Study

NCT04195984 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2025-02-13

No results posted yet for this study

Summary

To evaluate the safety and performance of the Mi-thos® Mitral Heart Valve with the Mi-thos® Transcatheter Delivery System.

Conditions

  • Mitral Valve Regurgitation

Interventions

DEVICE

Mi-thos® valve and transapical delivery system

Transcatheter mitral valve replacement system

Sponsors & Collaborators

  • Shanghai NewMed Medical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Wang chunsheng, Chief · Shanghai Zhongshan Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-25
Primary Completion
2026-05-31
Completion
2027-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04195984 on ClinicalTrials.gov